======= ANP32E ======= == Gene Information == * **Official Symbol**: ANP32E * **Official Name**: acidic nuclear phosphoprotein 32 family member E * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=81611|81611]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BTT0|Q9BTT0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ANP32E&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANP32E|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609611|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Histone chaperone that specifically mediates the genome- wide removal of histone H2A.Z/H2AFZ from the nucleosome: removes H2A.Z/H2AFZ from its normal sites of deposition, especially from enhancer and insulator regions. Not involved in deposition of H2A.Z/H2AFZ in the nucleosome. May stabilize the evicted H2A.Z/H2AFZ-H2B dimer, thus shifting the equilibrium towards dissociation and the off-chromatin state (PubMed:24463511). Inhibits activity of protein phosphatase 2A (PP2A). Does not inhibit protein phosphatase 1. May play a role in cerebellar development and synaptogenesis. {ECO:0000269|PubMed:24463511}. |LRR 4| |phosphatase inhibitor activity| |Swr1 complex| |histone exchange| |ATP-dependent chromatin remodeling| |histone binding| |nucleosome organization| |chromatin remodeling| |protein-DNA complex subunit organization| |cytoplasmic vesicle| |chromatin organization| |negative regulation of catalytic activity| |chromosome organization| |negative regulation of molecular function| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp123|GSK-LSD1 10μM R03 exp123]]|1.7| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|1.71| |[[:results:exp210|LB-100 2μM R05 exp210]]|1.79| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.9| |[[:results:exp11|CCCP 1μM R00 exp11]]|2.02| |[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|2.08| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|2.12| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|2.41| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|3.02| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 2/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|1/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3912 * **Expression level (log2 read counts)**: 7.99 {{:chemogenomics:nalm6 dist.png?nolink |}}